spacer
spacer

PDBsum entry 3mpm

Go to PDB code: 
protein ligands links
Transferase PDB id
3mpm

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
257 a.a. *
Ligands
5LK
EDO
Waters ×258
* Residue conservation analysis
PDB id:
3mpm
Name: Transferase
Title: Lck complexed with a pyrazolopyrimidine
Structure: Tyrosine-protein kinase lck. Chain: a. Fragment: unp residues 237-501. Synonym: proto-oncogene lck, lymphocyte cell-specific protein- tyrosine kinase, p56-lck, lsk, t cell-specific protein-tyrosine kinase. Engineered: yes. Mutation: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: lck. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108
Resolution:
1.95Å     R-factor:   0.172     R-free:   0.213
Authors: S.W.Cowan-Jacob,G.Rummel
Key ref: N.Gommermann et al. (2010). New pyrazolo[1,5a]pyrimidines as orally active inhibitors of Lck. Bioorg Med Chem Lett, 20, 3628-3631. PubMed id: 20483608
Date:
27-Apr-10     Release date:   02-Jun-10    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P06239  (LCK_HUMAN) -  Tyrosine-protein kinase Lck from Homo sapiens
Seq:
Struc:
509 a.a.
257 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

 Enzyme reactions 
   Enzyme class: E.C.2.7.10.2  - non-specific protein-tyrosine kinase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H+
L-tyrosyl-[protein]
+ ATP
= O-phospho-L-tyrosyl-[protein]
+ ADP
+ H(+)
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    Added reference    
 
 
Bioorg Med Chem Lett 20:3628-3631 (2010)
PubMed id: 20483608  
 
 
New pyrazolo[1,5a]pyrimidines as orally active inhibitors of Lck.
N.Gommermann, P.Buehlmayer, A.von Matt, W.Breitenstein, K.Masuya, B.Pirard, P.Furet, S.W.Cowan-Jacob, G.Weckbecker.
 
  ABSTRACT  
 
A novel series of pyrazolo[1,5a]pyrimidines was optimized to target lymphocyte-specific kinase (Lck). An efficient synthetic route was developed and SAR studies toward activity and selectivity are described, leading to Lck inhibitors with enzymatic, cellular and in vivo potency.
 

 

spacer

spacer